Homepage - Ophthalmology Advisor
This Domestic Violence Awareness Month, Psychiatry Advisor spoke with Allison Paugh to discuss best practices when encountering cases of suspected IPV during teletherapy.
FDA Drug Approval Decisions Expected in December 2024
Nov 15, 2024 · The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been accepted by the Agency.
Low Dose Pilocarpine Drop Shows Strong Efficacy
Nov 12, 2024 · CSF-1, a low-dose, preservative-free, pilocarpine ophthalmic solution, consistently reduces pupil size and improves visual outcomes for patients with presbyopia, according to the results of the phase 3, NEAR-1 study (Near Eye-vision Acuity Restoration; ClinicalTrials.gov identifier: NCT04599933) and NEAR-2 (ClinicalTrials.gov identifier: NCT04599972) study.
Ocular Myasthenia Gravis Treatment Options Explained
Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized by progressive fatigability of skeletal muscle limited to the orbicularis oculi, levator palpebrae superioris, and the extraocular muscles. 1 Up to half of patients diagnosed with MG present with ocular muscle weakness before ...
Cataract Therapy Eye Drop May Reverse Progression
Aug 22, 2024 · A cataract therapy eye drop designed to improve visual function in patients with contrast sensitivity (CS) loss due to cataracts is demonstrating that it can also reduce lens density in early phase trials, according to a report published in the American Journal of Ophthalmology.. The cataract therapy drop — referred to as C-KAD — contains an active ingredient, 2.6% ...
Curcuma-Based Nutritional Supplements Reduce AMD Risks
Oct 28, 2024 · A subgroup analysis exploring the supplement’s ability to limit disease progression risk revealed that patients with early nonexudative AMD were less likely to progress to advanced nonexudative AMD than individuals who did not use the supplement (4.32% vs 7.50%; P <.001).However, using curcuma-based nutritional supplements did not affect exudative AMD development risk.
Alcohol Consumption Worsens Glaucoma-Related Traits
Jan 5, 2023 · Alcohol intake has a consistent and adverse association with glaucoma and related traits, and at levels below current UK and US guidelines, according to a study published in Ophthalmology Glaucoma.. Researchers conducted a cross-sectional analysis to examine the associations of alcohol consumption with glaucoma and related traits, and to assess whether a genetic predisposition to glaucoma ...
FDA Extends Review of CNTF Ocular Implant for Macular …
Nov 20, 2024 · The Food and Drug Administration (FDA) has extended the review period for the Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) in the treatment of macular telangiectasia type 2 (MacTel).
How The Gut Microbiome Affects Ocular Health - Ophthalmology …
Feb 23, 2024 · The gut microbiome significantly affects digestion and — as research now shows — systemic inflammation. Recent literature has begun to explore a growing interest in how this microbiota affects organs beyond the digestive system, with researchers now believing that even several eye diseases have associations with gut dysbiosis.
With Preexisting Corneal Disease, Adjust Cataract Surgery Approach
Nov 22, 2023 · Cataract surgery is one of the most commonly performed procedures in ophthalmology and results are generally excellent. However, unique challenges can arise when a patient has preexisting corneal disease or has undergone a corneal procedure.